Cite
F638 A NITRIC OXIDE (NO)-DONATING GABAPENTIN, NCX 1236, REVERSES THE DEVELOPMENT OF MECHANICAL ALLODYNIA IN STREPTOZOTOCIN-TREATED DIABETIC MICE.
MLA
Impagnatiello, F. I., et al. “F638 a Nitric Oxide (No)-Donating Gabapentin, Ncx 1236, Reverses the Development of Mechanical Allodynia in Streptozotocin-Treated Diabetic Mice.” European Journal of Pain Supplements, vol. 5, no. 1, Sept. 2011, p. 180. EBSCOhost, https://doi.org/10.1016/S1754-3207(11)70618-6.
APA
Impagnatiello, F. I., Borea, P. A., Vincenzi, F., Targa, M., Borghi, V., & Varani, K. (2011). F638 a Nitric Oxide (No)-Donating Gabapentin, Ncx 1236, Reverses the Development of Mechanical Allodynia in Streptozotocin-Treated Diabetic Mice. European Journal of Pain Supplements, 5(1), 180. https://doi.org/10.1016/S1754-3207(11)70618-6
Chicago
Impagnatiello, F.I., P.A. Borea, F. Vincenzi, M. Targa, V. Borghi, and K. Varani. 2011. “F638 a Nitric Oxide (No)-Donating Gabapentin, Ncx 1236, Reverses the Development of Mechanical Allodynia in Streptozotocin-Treated Diabetic Mice.” European Journal of Pain Supplements 5 (1): 180. doi:10.1016/S1754-3207(11)70618-6.